266 related articles for article (PubMed ID: 27856497)
1. Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial.
Butler J; Epstein SE; Greene SJ; Quyyumi AA; Sikora S; Kim RJ; Anderson AS; Wilcox JE; Tankovich NI; Lipinski MJ; Ko YA; Margulies KB; Cole RT; Skopicki HA; Gheorghiade M
Circ Res; 2017 Jan; 120(2):332-340. PubMed ID: 27856497
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy.
Greene SJ; Epstein SE; Kim RJ; Quyyumi AA; Cole RT; Anderson AS; Wilcox JE; Skopicki HA; Sikora S; Verkh L; Tankovich NI; Gheorghiade M; Butler J
J Cardiovasc Med (Hagerstown); 2017 Apr; 18(4):283-290. PubMed ID: 26479144
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
[TBL] [Abstract][Full Text] [Related]
4. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.
Hare JM; Fishman JE; Gerstenblith G; DiFede Velazquez DL; Zambrano JP; Suncion VY; Tracy M; Ghersin E; Johnston PV; Brinker JA; Breton E; Davis-Sproul J; Schulman IH; Byrnes J; Mendizabal AM; Lowery MH; Rouy D; Altman P; Wong Po Foo C; Ruiz P; Amador A; Da Silva J; McNiece IK; Heldman AW; George R; Lardo A
JAMA; 2012 Dec; 308(22):2369-79. PubMed ID: 23117550
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
Tompkins BA; Rieger AC; Florea V; Banerjee MN; Natsumeda M; Nigh ED; Landin AM; Rodriguez GM; Hatzistergos KE; Schulman IH; Hare JM
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30005555
[TBL] [Abstract][Full Text] [Related]
6. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.
Heldman AW; DiFede DL; Fishman JE; Zambrano JP; Trachtenberg BH; Karantalis V; Mushtaq M; Williams AR; Suncion VY; McNiece IK; Ghersin E; Soto V; Lopera G; Miki R; Willens H; Hendel R; Mitrani R; Pattany P; Feigenbaum G; Oskouei B; Byrnes J; Lowery MH; Sierra J; Pujol MV; Delgado C; Gonzalez PJ; Rodriguez JE; Bagno LL; Rouy D; Altman P; Foo CW; da Silva J; Anderson E; Schwarz R; Mendizabal A; Hare JM
JAMA; 2014 Jan; 311(1):62-73. PubMed ID: 24247587
[TBL] [Abstract][Full Text] [Related]
7. Effects of transendocardial CD34+ cell transplantation in patients with ischemic cardiomyopathy.
Poglajen G; Sever M; Cukjati M; Cernelc P; Knezevic I; Zemljic G; Haddad F; Wu JC; Vrtovec B
Circ Cardiovasc Interv; 2014 Aug; 7(4):552-9. PubMed ID: 25097199
[TBL] [Abstract][Full Text] [Related]
8. Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy.
Luger D; Lipinski MJ; Westman PC; Glover DK; Dimastromatteo J; Frias JC; Albelda MT; Sikora S; Kharazi A; Vertelov G; Waksman R; Epstein SE
Circ Res; 2017 May; 120(10):1598-1613. PubMed ID: 28232595
[TBL] [Abstract][Full Text] [Related]
9. Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study).
Florea V; Rieger AC; DiFede DL; El-Khorazaty J; Natsumeda M; Banerjee MN; Tompkins BA; Khan A; Schulman IH; Landin AM; Mushtaq M; Golpanian S; Lowery MH; Byrnes JJ; Hendel RC; Cohen MG; Valasaki K; Pujol MV; Ghersin E; Miki R; Delgado C; Abuzeid F; Vidro-Casiano M; Saltzman RG; DaFonseca D; Caceres LV; Ramdas KN; Mendizabal A; Heldman AW; Mitrani RD; Hare JM
Circ Res; 2017 Nov; 121(11):1279-1290. PubMed ID: 28923793
[TBL] [Abstract][Full Text] [Related]
10. Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial.
Karantalis V; DiFede DL; Gerstenblith G; Pham S; Symes J; Zambrano JP; Fishman J; Pattany P; McNiece I; Conte J; Schulman S; Wu K; Shah A; Breton E; Davis-Sproul J; Schwarz R; Feigenbaum G; Mushtaq M; Suncion VY; Lardo AC; Borrello I; Mendizabal A; Karas TZ; Byrnes J; Lowery M; Heldman AW; Hare JM
Circ Res; 2014 Apr; 114(8):1302-10. PubMed ID: 24565698
[TBL] [Abstract][Full Text] [Related]
11. Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial.
Díez-Tejedor E; Gutiérrez-Fernández M; Martínez-Sánchez P; Rodríguez-Frutos B; Ruiz-Ares G; Lara ML; Gimeno BF
J Stroke Cerebrovasc Dis; 2014; 23(10):2694-2700. PubMed ID: 25304723
[TBL] [Abstract][Full Text] [Related]
12. Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.
Hare JM; DiFede DL; Rieger AC; Florea V; Landin AM; El-Khorazaty J; Khan A; Mushtaq M; Lowery MH; Byrnes JJ; Hendel RC; Cohen MG; Alfonso CE; Valasaki K; Pujol MV; Golpanian S; Ghersin E; Fishman JE; Pattany P; Gomes SA; Delgado C; Miki R; Abuzeid F; Vidro-Casiano M; Premer C; Medina A; Porras V; Hatzistergos KE; Anderson E; Mendizabal A; Mitrani R; Heldman AW
J Am Coll Cardiol; 2017 Feb; 69(5):526-537. PubMed ID: 27856208
[TBL] [Abstract][Full Text] [Related]
13. Intramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function: Results of the MESAMI 1 pilot trial.
Guijarro D; Lebrin M; Lairez O; Bourin P; Piriou N; Pozzo J; Lande G; Berry M; Le Tourneau T; Cussac D; Sensebe L; Gross F; Lamirault G; Huynh A; Manrique A; Ruidavet JB; Elbaz M; Trochu JN; Parini A; Kramer S; Galinier M; Lemarchand P; Roncalli J
Int J Cardiol; 2016 Apr; 209():258-65. PubMed ID: 26901787
[TBL] [Abstract][Full Text] [Related]
14. Phase I/II Study of Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Chronic Stroke.
Levy ML; Crawford JR; Dib N; Verkh L; Tankovich N; Cramer SC
Stroke; 2019 Oct; 50(10):2835-2841. PubMed ID: 31495331
[TBL] [Abstract][Full Text] [Related]
15. Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction: The Randomized Multicenter Double-Blind Controlled CAREMI Trial (Cardiac Stem Cells in Patients With Acute Myocardial Infarction).
Sanz-Ruiz R; Casado Plasencia A; Borlado LR; Fernández-Santos ME; Al-Daccak R; Claus P; Palacios I; Sádaba R; Charron D; Bogaert J; Mulet M; Yotti R; Gilaberte I; Bernad A; Bermejo J; Janssens S; Fernández-Avilés F
Circ Res; 2017 Jun; 121(1):71-80. PubMed ID: 28533209
[TBL] [Abstract][Full Text] [Related]
16. Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy.
Karantalis V; Suncion-Loescher VY; Bagno L; Golpanian S; Wolf A; Sanina C; Premer C; Kanelidis AJ; McCall F; Wang B; Balkan W; Rodriguez J; Rosado M; Morales A; Hatzistergos K; Natsumeda M; Margitich I; Schulman IH; Gomes SA; Mushtaq M; DiFede DL; Fishman JE; Pattany P; Zambrano JP; Heldman AW; Hare JM
J Am Coll Cardiol; 2015 Nov; 66(18):1990-1999. PubMed ID: 26516002
[TBL] [Abstract][Full Text] [Related]
17. Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit
Bolli R; Hare JM; March KL; Pepine CJ; Willerson JT; Perin EC; Yang PC; Henry TD; Traverse JH; Mitrani RD; Khan A; Hernandez-Schulman I; Taylor DA; DiFede DL; Lima JAC; Chugh A; Loughran J; Vojvodic RW; Sayre SL; Bettencourt J; Cohen M; Moyé L; Ebert RF; Simari RD;
Circ Res; 2018 Jun; 122(12):1703-1715. PubMed ID: 29703749
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial).
Mathiasen AB; Qayyum AA; Jørgensen E; Helqvist S; Fischer-Nielsen A; Kofoed KF; Haack-Sørensen M; Ekblond A; Kastrup J
Eur Heart J; 2015 Jul; 36(27):1744-53. PubMed ID: 25926562
[TBL] [Abstract][Full Text] [Related]
19. Phase I Clinical Trial of Autologous Stem Cell-Sheet Transplantation Therapy for Treating Cardiomyopathy.
Miyagawa S; Domae K; Yoshikawa Y; Fukushima S; Nakamura T; Saito A; Sakata Y; Hamada S; Toda K; Pak K; Takeuchi M; Sawa Y
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28381469
[TBL] [Abstract][Full Text] [Related]
20. Study design and rationale for ELPIS: A phase I/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome.
Kaushal S; Wehman B; Pietris N; Naughton C; Bentzen SM; Bigham G; Mishra R; Sharma S; Vricella L; Everett AD; Deatrick KB; Huang S; Mehta H; Ravekes WA; Hibino N; Difede DL; Khan A; Hare JM
Am Heart J; 2017 Oct; 192():48-56. PubMed ID: 28938963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]